Not Yet Recruiting PHASE3 INTERVENTIONAL 2-arm
NCT06957704
Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents
Sponsor: Federal University of São Paulo
Conditions
Depressive Disorder Suicidal Ideas
Updated 1 time since 2025 Last updated: May 2, 2025 Started: May 31, 2025 Primary completion: Apr 30, 2028 Completion: Apr 30, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06957704, this PHASE3 trial focuses on Depressive Disorder and Suicidal Ideas and remains actively recruiting participants. Sponsored by Federal University of São Paulo, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Federal University of São Paulo
Data source: Federal University of São Paulo
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.